tm logo
EMPIRICO
Dead/Abandoned
ABANDONED - NO STATEMENT OF USE FILED

no statement of use filed

on 25 Sep 2023

Last Applicant/ Owned by

4660 La Jolla Village Drive, Suite 100

San Diego

CA

92122

Serial Number

88977640 filed on 31st Dec 2018

Registration Number

N/A

Correspondent Address

Chelsea E. Carbone

Chelsea E. Carbone

650 PAGE MILL ROAD

PALO ALTO, CA 94304-1050

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

EMPIRICO

Pharmaceutical preparations for preventing or treating diseases of the cardiovascular system, diseases of the endocrine system, diseases of the gastrointestinal system, diseases of aging, diseases of the blood, diseases of the liver, diseases of the kidney, diseases of the nervous system, cancer, metabolic diseases, diseases of the immune system, diseases of the respiratory system, diseases of the Read More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for preventing or treating diseases of the cardiovascular system, diseases of the endocrine system, diseases of the gastrointestinal system, diseases of aging, diseases of the blood, diseases of the liver, diseases of the kidney, diseases of the nervous system, cancer, metabolic diseases, diseases of the immune system, diseases of the respiratory system, diseases of the musculoskeletal system, diseases of the genitourinary system, diseases of the skin, diseases of the eye, diseases of the auditory system, diseases of the reproductive system, psychiatric diseases, allergic diseases and infectious diseases; pharmaceutical preparations for use in angiology, cardiology, endocrinology, gastroenterology, geriatrics, hematology, hepatology, nephrology, neurology, oncology, pulmonology, pneumology, respirology, rheumatology, anesthesiology, urology, dermatology, gynecology, ophthalmology, infectiology, and psychiatry, particularly for preventing or treating diseases of the cardiovascular system, diseases of the endocrine system, diseases of the gastrointestinal system, diseases of aging, diseases of the blood, diseases of the liver, diseases of the kidney, diseases of the nervous system, cancer, metabolic diseases, diseases of the immune system, diseases of the respiratory system, diseases of the musculoskeletal system, diseases of the genitourinary system, diseases of the skin, diseases of the eye, diseases of the auditory system, diseases of the reproductive system, psychiatric diseases, allergic diseases and infectious diseases; pharmaceutical preparations for use in pediatric, geriatric, emergency, family, and preventative medicine, particularly for preventing or treating diseases of the cardiovascular system, diseases of the endocrine system, diseases of the gastrointestinal system, diseases of aging, diseases of the blood, diseases of the liver, diseases of the kidney, diseases of the nervous system, cancer, metabolic diseases, diseases of the immune system, diseases of the respiratory system, diseases of the musculoskeletal system, diseases of the genitourinary system, diseases of the skin, diseases of the eye, diseases of the auditory system, diseases of the reproductive system, psychiatric diseases, allergic diseases and infectious diseases; pharmaceutical preparations for the treatment of infectious, deficiency, hereditary, and physiological diseases

Mark Details


Serial Number

No 88977640

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 54462-TM1002

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
25th Sep 2023ABANDONMENT - NO USE STATEMENT FILED
25th Sep 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
20th Jan 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
19th Jan 2023SOU EXTENSION 5 GRANTED
17th Jan 2023SOU TEAS EXTENSION RECEIVED
17th Jan 2023SOU EXTENSION 5 FILED
05th Aug 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03rd Aug 2022SOU TEAS EXTENSION RECEIVED
03rd Aug 2022SOU EXTENSION 4 FILED
03rd Aug 2022SOU EXTENSION 4 GRANTED